West Point Resources Inc. to be Quoted on U.S. OTC Pink Marketplace, Symbol BLOZF

Vancouver, August 6, 2014 - West Point Resources Inc. (CSE: BLO, OTC PINK: BLOZF) (the "Company") is pleased to announce West Point Resources Inc. will begin trading on the OTC Pinksheets under the symbol "BLOZF" on August 7, 2014. U.S. investors can find quotes for the company on www.otcmarkets.com. West Point is listed on the Canadian Securities Exchange (the CSE), symbol "BLO".

West Point is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed in Sweden and has been clinically researched to be successful in testing individuals for recent consumption of the THC component of marijuana. West Point is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in various jurisdictions. West Point is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide rapid detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device could also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.

We seek Safe Harbor.


On behalf of the Board of Directors

"Rav Mlait"
West Point Resources Inc.



For further information, contact the Company's CEO, Rav Mlait 604-551-7831 email at info@westpointresources.com



The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.


Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as final development of a commercial or prototype product(s), successful trial or pilot of company technologies, no assurance that commercial sales of any kind actually materialize; no assurance the Company will have sufficient funds to complete product development. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks regarding protection of proprietary technology; (iii) the ability of the Company to complete financings; (v) the ability of the Company to develop and market its future product; and (vi) risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that the marijuana breathalyzer business will provide any benefit to the Company, and no assurance that any proposed new products will be built or proceed. There is no assurance that existing "patent pending" technologies licensed by the Company will receive patent status by regulatory authorities. The Company is not currently selling commercial breathalyzers. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.